Nation

New Covid 19 vaccine Covavax soon to arrive in India

As India gears up its vaccination process, another new vaccine makes its name in the list of its vaccination chart

Published:
17 Jun 2021 09:00am IST

The US-based technology company Novavax has tied up with Serum Institute of India to manufacture its Covid 19 vaccine named COVAVAX.

The CEO of Novavax, Stanley Erck, said that this vaccine has 90% efficacy and gives 100% protection against moderate to severe disease.

Trials have been completed on 29,960 voluntary participants over 119 sites in UK and Mexico.

The Covavax is scheduled to be launched in India by September 2021. The Government of India will be getting a total of 200 million doses from the Serum Institute of India.

The trials concluded that the new vaccine works equivalent and similarly effective as the other vaccines in the market. This vaccine has the power to fight against all the variants of Covid, including the Delta variant.

**Image:** a sample of the Novavax vaccine

In India, while addressing a press conference, NITI Aayog member Dr VK Paul said that it is a protein subunit vaccine and will be administered in two doses. Paul added that it gained acceptance at high levels.

The Covavax is scheduled to be launched in India by September 2021.

The Government of India will be getting a total of 200 million doses from the Serum Institute of India.